Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Mallinckrodt
McKesson
Moodys
Dow

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Cetrorelix - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cetrorelix and what is the scope of freedom to operate?

Cetrorelix is the generic ingredient in one branded drug marketed by Emd Serono Inc and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Cetrorelix has twenty-eight patent family members in twenty-two countries.

There is one drug master file entry for cetrorelix. One supplier is listed for this compound.

Summary for cetrorelix
Recent Clinical Trials for cetrorelix

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 4
ShangHai Ji Ai Genetics & IVF InstituteN/A
ClinAmygatePhase 4

See all cetrorelix clinical trials

Synonyms for cetrorelix
(S)-1-(((R)-2-((S)-2-((S)-2-((R)-2-((R)-2-((R)-2-acetamido-3-(naphthalen-2-yl)propanamido)-3-(4-chlorophenyl)propanamido)-3-(pyridin-3-yl)propanamido)-3-hydroxypropanamido)-3-(4-hyd
120287-85-6
130143-01-0
287C856
ABP000574
Ac-(D-Ala[3-(2-Naphthyl)])-[D-Phe(4-Cl)]-(D-Ala[3-(3-Pyridyl)])-Ser-Tyr-(D-Cit)-Leu-Arg-Pro-D-Ala-Oh
AC-28734
Ac-D-Nal(2)-D-Phe(pCl)-D-Pal(3)-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2
AKOS015994648
BDBM50369965
C-35500
C70H92ClN17O14
Cetrelix Acetate
Cetrorelix (INN)
Cetrorelix [INN:BAN]
Cetrorelix acetate
Cetrorelix Acetate(Cetrotide)/
Cetrorelix(Cetrorelix acetate)
Cetrorelixum
Cetrorelixum [INN-Latin]
Cetrotide
Cetrotide (TN)
CHEBI:59224
CHEMBL1200490
D07665
DB00050
DTXSID7040996
FT-0647968
FT-0656251
GTPL1190
HS-2008
HSDB 7696
KS-00002WUP
MolPort-009-194-176
MolPort-042-652-596
N-acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N5-carbomoyl-D-ornithyl-L-leucyl-L-prolyl-D-alaninamide
N-Acetyl-3-(2-naphthyl)-D-alanyl-p-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N(sup 5)-carbamoyl-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide
N-acetyl-3-(naphthalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-L-tyrosyl-N(5)-carbamoyl-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide
NCGC00485296-01
OON1HFZ4BA
roxyphenyl)propanamido)-5-ureidopentanoyl)-L-leucyl-L-arginyl)-N-((R)-1-amino-1-oxopropan-2-yl)pyrrolidine-2-carboxamide
SB 75
SB-075
SC-50568
SC-82639
SCHEMBL19712202
SCHEMBL61331
UNII-OON1HFZ4BA
V0412
Y-100040

US Patents and Regulatory Information for cetrorelix

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd Serono Inc CETROTIDE cetrorelix INJECTABLE;INJECTION 021197-001 Aug 11, 2000 RX Yes Yes   Start Trial   Start Trial   Start Trial
Emd Serono Inc CETROTIDE cetrorelix INJECTABLE;INJECTION 021197-002 Aug 11, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for cetrorelix

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd Serono Inc CETROTIDE cetrorelix INJECTABLE;INJECTION 021197-002 Aug 11, 2000   Start Trial   Start Trial
Emd Serono Inc CETROTIDE cetrorelix INJECTABLE;INJECTION 021197-001 Aug 11, 2000   Start Trial   Start Trial
Emd Serono Inc CETROTIDE cetrorelix INJECTABLE;INJECTION 021197-001 Aug 11, 2000   Start Trial   Start Trial
Emd Serono Inc CETROTIDE cetrorelix INJECTABLE;INJECTION 021197-002 Aug 11, 2000   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for cetrorelix

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0299402 C990029 Netherlands   Start Trial PRODUCT NAME: CETRORELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR DBAAR ZUUR ADDITIEZOUT, IN HET BIJZONDER CETRORELIX ACETAAT; REGISTRATION NO/DATE: EU/1/99/100/001-003 19990413
0299402 31/1999 Austria   Start Trial PRODUCT NAME: CETRORELIX UND PHARMAZEUTISCH ANNEHMBARE SAEUREADDITIONSSALZE DAVON, INSBESONDERE CETRORELIXACETAT; REGISTRATION NO/DATE: EU/1/99/100/001- EU/1/99/100/003 19990413
0299402 099C0031 Belgium   Start Trial PRODUCT NAME: ACETATE DE CETRORELIX; REGISTRATION NO/DATE: EU/1/99/100/001 19990413
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Dow
Baxter
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.